UA10335A - Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology - Google Patents

Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology

Info

Publication number
UA10335A
UA10335A UA93005621A UA93005621A UA10335A UA 10335 A UA10335 A UA 10335A UA 93005621 A UA93005621 A UA 93005621A UA 93005621 A UA93005621 A UA 93005621A UA 10335 A UA10335 A UA 10335A
Authority
UA
Ukraine
Prior art keywords
disease
clamydiae
reiter
etiology
patients
Prior art date
Application number
UA93005621A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Іван Іванович Мавров
Иван Иванович Мавров
Марія Степанівна Гоначаренко
Мария Степановна Гоначаренко
Анна Костянтинівна Кондакова
Анна Константиновна Кондакова
Вікторія Олександрівна Савоськіна
Виктория Александровна Савоскина
Original Assignee
Український Науково-Дослідний Інститут Дерматології І Венерології
Украинский научно-исследовательский институт дерматологии и венерологии
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Дерматології І Венерології, Украинский научно-исследовательский институт дерматологии и венерологии filed Critical Український Науково-Дослідний Інститут Дерматології І Венерології
Priority to UA93005621A priority Critical patent/UA10335A/en
Publication of UA10335A publication Critical patent/UA10335A/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method for correction of the calcium metabolism abnormality in patients with the Reiter's disease of clamydiae etiology comprises therapy with antibiotics. Preparationsof the Verapamil group having calcium-antagonist action are additionally prescribed, for example, oral Finoptin, and in the case of torpid forms of disease – intravenous Isoptin. The invention relates to medicine and may be used for treatment of the Reiter's disease syndrome of of clamydiae etiology.
UA93005621A 1993-04-21 1993-04-21 Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology UA10335A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA93005621A UA10335A (en) 1993-04-21 1993-04-21 Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA93005621A UA10335A (en) 1993-04-21 1993-04-21 Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology

Publications (1)

Publication Number Publication Date
UA10335A true UA10335A (en) 1996-12-25

Family

ID=74552500

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93005621A UA10335A (en) 1993-04-21 1993-04-21 Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology

Country Status (1)

Country Link
UA (1) UA10335A (en)

Similar Documents

Publication Publication Date Title
NO951592L (en) Process for the preparation of a transdermal therapeutic system
TW250435B (en)
UA56989C2 (en) PHYSIOLOGICALLY ACTIVE PEG-CONJUGATE OF a-INTERFERON, A METHOD FOR PREPARING THE SAME, A PHARMACEUTICAL COMPOSITION BASED THEREON AND A METHOD FOR TREATMENT OR PROPHYLAXIS OF IMMUNOMODULAR DISEASES
CA2164866A1 (en) Treatment of neuromuscular disorders and conditions with different botulinum serotype
IL134345A0 (en) Methods for treatment of patients afflicted with multiple sclerosis using consensus interferon
CA2125662A1 (en) Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis
PT97785A (en) METHOD FOR IMPROVING TREATMENT USING, FOR EXAMPLE, DOXAZOSINE
HU9301253D0 (en) Medical preparative applicable for treatment of enlarged time of coagulation
NO994165L (en) Use of descarboethoxyloratadine for the manufacture of a medicament for the treatment of urinary incontinence, travel sickness and dizziness
NO882853D0 (en) CORRECTION WITH DOUBLE-THREADED RNA OF ANNORMAL CONDITIONS IN IMMUNE COMPLEXES WHICH ARE IN ORDER AND IN MONOCYT FUNCTION.
DK0668077T3 (en) Products containing G-CSF and TNF-binding protein
FI962685A0 (en) Use of 2,3-diaryl-1-benzopyran derivatives in the manufacture of a medicament for the treatment and prevention of bone loss and osteoporosis
DK0781560T3 (en) Use of immunoglobulin preparations for the manufacture of a medicament for oral administration for treatment and prevention
EP1006793A4 (en) Anti-arrhythmic composition and methods of treatment
DK0629400T3 (en) Idebenone-containing preparations for the treatment of Alzheimer's disease
EP0744176A3 (en) Methods for inhibiting bone loss
GR3007995T3 (en)
UA10335A (en) Method for correction of the calcium metabolism abnormality in patients with the reiter's disease of clamydiae etiology
NO874241D0 (en) THERAPEUTIC ACTIVE SALTS.
PT711163E (en) USE OF BENZIDAMINE IN THE TREATMENT OF TNF-INDUCED PATHOLOGICAL STATES
EP0182569A3 (en) Use of 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyridoû1,2-a¨pyrimidine-3-carboxamide for the prevention and treatment of gastrointestinal damages
GR3037039T3 (en) Use of trimetazidine for the preparation of medicaments for the treatment of troubles due to the therapeutical use of immunosuppressants.
RU95116781A (en) METHOD FOR TREATING EPILEPSY PATIENTS
FR2700337B1 (en) Imidazopyridine-2-one derivatives, their preparation process and their use in therapy.
UA19596A (en) Method for hypertension desease treatment by hirudoreflexotherapy